Zhejiang Zhixin Pharmaceutical Co., Ltd., located in Yuhang District, Hangzhou, is a high-tech enterprise specializing in the research and development of generic drugs and improved new drugs. The company has a total R&D laboratory area of approximately 1,600 square meters. One facility, situated within Zhejiang Zhebei Pharmaceutical Co., Ltd., covers about 1,200 square meters and focuses on the R&D of small-molecule active pharmaceutical ingredients (APIs), formulations, and polypeptides. The other facility, located in the Zhejiang High-Level Overseas Talent Innovation Park, spans around 330 square meters and is primarily responsible for the holding and management of the "B Certificate" (MAH license).

The company is equipped with advanced instruments such as high-performance liquid chromatography (HPLC) systems, gas chromatography (GC) systems, osmometers, insoluble particle analyzers, analytical balances, and reactors ranging from 10 mL to 500 L, meeting the needs of liquid formulation and API development. Currently, the company employs 23 technical staff, including 4 master’s degree holders, 5 engineers, and 1 senior engineer.

Production operations are supported by partnerships with Zhejiang Zhebei Pharmaceutical Co., Ltd., Jiangsu Hengxin Pharmaceutical Co., Ltd., and Heilongjiang Hengxin Pharmaceutical Co., Ltd. Grounded in scientific research and committed to client interests, Zhixin Pharmaceutical adheres to drug development principles. Through a comprehensive, standardized R&D system and rapid, efficient, high-quality services, the company empowers Chinese pharmaceutical enterprises via the Marketing Authorization Holder (MAH) system. Upholding the philosophy of "Commitment to Ambition, Shared Success, Innovation for the Future, and Health for All," Zhixin Pharmaceutical strives to advance global health through collaborative excellence.